CHINA PHARMA HOLDINGS, INC. Earnings Per Share (Basic)
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Earnings Per Share (Basic) of -$0.04 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.04.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.04.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.18.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.17.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic for fiscal 2025 was -$0.74.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic for fiscal 2024 was -$2.71.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic for fiscal 2023 was -$0.91.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic for fiscal 2022 was -$3.78.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.04 10-Q · filed 2026-08-14 | -$0.08 10-Q · filed 2026-08-14 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | -$0.04 10-Q · filed 2026-05-15 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.74 10-K · filed 2026-04-01 | ||||
| 2025-09-30 | -$0.17 10-Q · filed 2025-11-12 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.57 10-Q · filed 2025-11-12 | -$1.01 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$0.16 10-Q · filed 2026-08-14 | -$0.40 10-Q · filed 2026-08-14 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-03-31 | -$0.24 10-Q · filed 2026-05-15 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.05 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2024-12-31 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$2.01 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$2.71 10-K · filed 2026-04-01 | -$0.27 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$0.65 10-Q · filed 2025-11-12 | -$0.06 10-Q · filed 2024-11-13 | -$1.53 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$2.25 10-Q · filed 2025-11-12 | -$0.23 10-Q · filed 2024-11-13 | -$1.59 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||
| 2024-06-30 | -$0.89 10-Q · filed 2025-08-14 | -$0.09 10-Q · filed 2024-08-14 | -$1.63 10-Q · filed 2025-08-14 | -$0.16 10-Q · filed 2024-08-14 | -$1.06 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.37 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||
| 2024-03-31 | -$0.72 10-Q · filed 2025-05-14 | -$0.51 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.79 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.10 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2023-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.67 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.91 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$0.29 10-Q · filed 2024-11-13 | -$0.06 10-Q · filed 2023-11-13 | -$0.63 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.89 10-Q · filed 2024-11-13 | -$0.18 10-Q · filed 2023-11-13 | -$6.14 derived: net income ÷ weighted average shares · filed 2024-11-13 | ||
| 2023-06-30 | -$0.35 10-Q · filed 2024-08-14 | -$0.06 10-Q · filed 2023-08-14 | -$0.65 10-Q · filed 2024-08-14 | -$0.12 10-Q · filed 2023-08-14 | $11.34 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$2.85 derived: net income ÷ weighted average shares · filed 2024-11-13 | ||
| 2023-03-31 | -$0.06 10-Q · filed 2023-05-12 | $1.51 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$2.82 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$1.81 derived: net income ÷ weighted average shares · filed 2024-11-13 | ||||
| 2022-12-31 | $0.12 derived: net income ÷ weighted average shares · filed 2024-04-01 | $0.76 derived: net income ÷ weighted average shares · filed 2024-04-01 | $16.53 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$3.78 10-K · filed 2024-04-01 | -$0.76 10-K · filed 2023-03-30 | |||
| 2022-09-30 | -$0.16 10-Q · filed 2023-11-13 | -$0.02 10-Q · filed 2022-11-14 | -$0.34 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.56 10-Q · filed 2023-11-13 | -$0.06 10-Q · filed 2022-11-14 | $0.14 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||
| 2022-06-30 | -$0.18 10-Q · filed 2023-08-14 | -$0.02 10-Q · filed 2022-08-11 | -$0.40 10-Q · filed 2023-08-14 | -$0.04 10-Q · filed 2022-08-11 | $0.08 derived: net income ÷ weighted average shares · filed 2023-11-13 | $0.24 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||
| 2022-03-31 | -$0.22 10-Q · filed 2023-05-12 | -$0.02 10-Q · filed 2022-05-12 | $0.04 derived: net income ÷ weighted average shares · filed 2023-11-13 | $0.13 derived: net income ÷ weighted average shares · filed 2023-11-13 | $0.67 derived: net income ÷ weighted average shares · filed 2023-11-13 | |||
| 2021-12-31 | $0.01 derived: net income ÷ weighted average shares · filed 2023-03-30 | $0.05 derived: net income ÷ weighted average shares · filed 2023-03-30 | $0.30 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.74 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$0.02 10-Q · filed 2022-11-14 | -$0.04 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.05 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$0.02 10-Q · filed 2022-08-11 | -$0.03 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | -$0.02 10-Q · filed 2022-05-12 | |||||||
| 2016-09-30 | -$0.04 10-Q · filed 2016-11-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2017-11-14 | -$0.13 10-Q · filed 2016-11-14 | -$0.28 derived: net income ÷ weighted average shares · filed 2017-11-14 | ||||
| 2016-06-30 | -$0.06 10-Q · filed 2016-08-11 | -$0.09 10-Q · filed 2016-08-11 | -$0.24 derived: net income ÷ weighted average shares · filed 2017-08-14 | -$0.17 derived: net income ÷ weighted average shares · filed 2017-08-14 | ||||
| 2016-03-31 | -$0.04 10-Q · filed 2016-05-16 | -$0.18 derived: net income ÷ weighted average shares · filed 2017-05-11 | -$0.11 derived: net income ÷ weighted average shares · filed 2017-05-11 | -$0.09 derived: net income ÷ weighted average shares · filed 2017-05-11 | ||||
| 2015-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2017-03-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2017-03-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2017-03-31 | -$0.35 10-K · filed 2016-03-30 | ||||
| 2015-09-30 | $0.07 10-Q · filed 2016-11-14 | -$0.10 10-Q · filed 2015-11-16 | $0.09 derived: net income ÷ weighted average shares · filed 2016-11-14 | -$0.21 10-Q · filed 2016-11-14 | -$0.37 10-Q · filed 2015-11-16 | |||
| 2015-06-30 | $0.03 10-Q · filed 2016-08-11 | -$0.09 10-Q · filed 2015-08-14 | -$0.16 10-Q · filed 2016-08-11 | -$0.28 10-Q · filed 2015-08-14 | ||||
| 2015-03-31 | -$0.09 10-Q · filed 2016-05-16 | -$0.18 10-Q · filed 2015-05-11 | ||||||
| 2014-12-31 | -$0.91 10-K · filed 2016-03-30 | -$0.60 10-K · filed 2015-03-30 | ||||||
| 2014-09-30 | -$0.15 10-Q · filed 2015-12-28 | -$0.40 10-Q · filed 2015-12-28 | ||||||
| 2014-06-30 | -$0.20 10-Q · filed 2015-12-28 | -$0.25 10-Q · filed 2015-12-28 | ||||||
| 2014-03-31 | -$0.05 10-Q · filed 2015-12-28 | |||||||
| 2013-12-31 | -$0.46 10-K · filed 2015-12-28 | |||||||
| 2013-09-30 | -$0.05 10-Q · filed 2014-11-14 | -$0.22 10-Q · filed 2014-11-14 | ||||||
| 2013-06-30 | -$0.10 10-Q · filed 2014-08-14 | -$0.17 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | -$0.06 10-Q · filed 2014-05-15 | |||||||
| 2012-12-31 | $0.11 10-K · filed 2014-03-20 | |||||||
| 2012-09-30 | $0.03 10-Q · filed 2013-11-14 | $0.13 10-Q · filed 2013-11-14 | ||||||
| 2012-06-30 | $0.04 10-Q · filed 2013-08-14 | $0.10 10-Q · filed 2013-08-14 | ||||||
| 2012-03-31 | $0.06 10-Q · filed 2013-05-14 | |||||||
| 2011-12-31 | $0.44 10-K · filed 2013-03-14 | |||||||
| 2011-09-30 | $0.11 10-Q · filed 2012-11-14 | $0.08 10-Q · filed 2011-11-10 | $0.35 10-Q · filed 2012-11-14 | $0.31 10-Q · filed 2011-11-10 | ||||
| 2011-06-30 | $0.12 10-Q · filed 2012-08-14 | $0.23 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | $0.12 10-Q · filed 2012-05-14 | |||||||
| 2010-12-31 | $0.54 10-K · filed 2012-03-14 | |||||||
| 2010-09-30 | $0.14 10-Q/A · filed 2012-03-06 | $0.39 10-Q/A · filed 2012-03-06 | ||||||
| 2010-06-30 | $0.14 10-Q/A · filed 2011-09-06 | $0.25 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |